Seres Therapeutics
MCRB
#8982
Rank
NZ$0.17 B
Marketcap
$0.98
Share price
-3.90%
Change (1 day)
-19.42%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -NZ$0.22 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.24 Billion34.63%
2023 -NZ$0.18 Billion-59.97%
2022 -NZ$0.44 Billion289.57%
2021 -NZ$0.12 Billion-27.3%
2020 -NZ$0.16 Billion23%
2019 -NZ$0.13 Billion-30.11%
2018 -NZ$0.18 Billion9.73%
2017 -NZ$0.17 Billion-0.74%
2016 -NZ$0.17 Billion70.96%
2015 -NZ$95.92 Million257.11%
2014 -NZ$26.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.44 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.46 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.76 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA